depatuxizumab mafodotin

Ligand id: 7970

Name: depatuxizumab mafodotin

Compound class Antibody
International Nonproprietary Names
INN number INN
10263 depatuxizumab mafodotin
Database Links
GtoPdb PubChem SID 249565653
Search PubMed clinical trials depatuxizumab mafodotin
Search PubMed titles depatuxizumab mafodotin
Search PubMed titles/abstracts depatuxizumab mafodotin
Depatuxizumab mafodotin (ABT-414) is an antibody-drug conjugate (ADC), which targets a unique tomour-specific EGFR epitope in some cancer cells [5]. The antibody portion recognises EGFR in glioblastoma cells with EGFR gene amplification or expressing the truncated Δ2-7 EGFR mutant (aka EGFRvIII) [2-3]. The antibody is linked to the cytotoxic agent, monomethyl auristatin F (MMAF; PubChem CID 56841603) (information derived from Phillips et al. (2013) [4] and Abbvie's webpage for oncology pipeline compounds and references therein [1].